Edesa Biotech Income
What is the Income of Edesa Biotech?
The Income of Edesa Biotech, Inc. is -$6.93
What is the definition of Income?
Net income available for common shareholders equals net income minus preferred dividends paid.
ttm (trailing twelve months)
Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.
Income of companies in the Health Care sector on NASDAQ compared to Edesa Biotech
What does Edesa Biotech do?
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Companies with income similar to Edesa Biotech
- Guardforce AI Co has Income of -CAD$6.96
- Unigold has Income of -CAD$6.96
- Convey Parent has Income of -$6.95
- DSG Global has Income of -$6.94
- Immuron has Income of -AUD$6.94
- Park Lawn has Income of -$6.93
- Edesa Biotech has Income of -$6.93
- Ceva has Income of -$6.93
- EnWave has Income of -CAD$6.93
- Theranexus SA has Income of -€6.92
- C-MER Eye Care has Income of -HKD$6.92
- HireRight Corp has Income of -$6.92
- Hydrodec plc has Income of -$6.92